Lu X, Sinha A K, Weiss H R
Department of Physiology & Biophysics, UMDNJ-Robert Wood Medical School, Piscataway, New Jersey 08854-5635, USA.
Neurochem Res. 1997 Jun;22(6):705-11. doi: 10.1023/a:1027354110563.
This investigation tested the importance of excitatory amino acids' effects on regional cerebral O2 consumption and the concomitant changes in cerebral blood flow (rCBF) in isoflurane anesthetized rats. In the glutamate or N-methyl-D-aspartate (NMDA) groups, 10(-2) M glutamate or NMDA was topically applied to the right cortex and the left cortex was used as a control. One mg/kg dizocilpine maleate (MK-801), a non-competitive NMDA receptor antagonist, was administered (iv) to the MK-801 group and saline was given to the control group. Cortical rCBF was determined using 14C-iodoantipyrine and regional O2 extraction was measured microspectrophotometrically. Cerebral O2 consumption increased 77% after glutamate (contralateral cortex: 9.0 +/- 1.1 ml O2/min/100 g, glutamate treated cortex: 15.9 +/- 3.9), while a 46% increase was observed with the same concentration of NMDA (contralateral cortex: 9.8 +/- 2.0, NMDA treated cortex: 14.3 +/- 5.5). After MK-801, the O2 consumption decreased to 37% of the control value (control cortex: 7.0 +/- 1.3, MK-801 treated cortex: 2.6 +/- 3.9). MK-801 significantly decreased cerebral O2 extraction from 7.1 +/- 1.3 ml O2/100 ml (control cortex) to 5.3 +/- 0.6 (MK-801 treated cortex). However, there was no significant difference in cerebral O2 extraction between treated and contralateral cortex in either the glutamate or NMDA groups. The increase in O2 consumption caused by glutamate or NMDA was coupled with increased rCBF. Glutamate increased rCBF from 95 +/- 5 ml/min/100 g (contralateral cortex) to 165 +/- 31 (treated cortex), while NMDA increased rCBF from 114 +/- 12 (contralateral cortex) to 178 +/- 60 (treated cortex). MK-801 decreased O2 consumption with a lesser decrease of rCBF. The rCBF was 48 +/- 9 in the MK-801 treated cortex and 99 +/- 22 in the control cortex. Some substances produced by the activation of NMDA receptors may be related to the coupling of cerebral metabolism and blood flow, since after blockade of NMDA receptors with MK-801, this relationship is uncoupled. These findings suggest that glutamatergic processes have a major effect on cerebral O2 consumption and that this is at least partly due to NMDA receptors.
本研究检测了兴奋性氨基酸对异氟烷麻醉大鼠局部脑氧消耗及伴随的脑血流量(rCBF)变化的影响。在谷氨酸或N-甲基-D-天冬氨酸(NMDA)组中,将10(-2)M谷氨酸或NMDA局部应用于右侧皮层,左侧皮层作为对照。给MK-801组静脉注射1mg/kg马来酸氯氮平(MK-801),一种非竞争性NMDA受体拮抗剂,对照组给予生理盐水。使用14C-碘安替比林测定皮层rCBF,并用显微分光光度法测量局部氧摄取。谷氨酸作用后脑氧消耗增加77%(对侧皮层:9.0±1.1ml O2/min/100g,谷氨酸处理皮层:15.9±3.9),相同浓度的NMDA作用后增加46%(对侧皮层:9.8±2.0,NMDA处理皮层:14.3±5.5)。MK-801作用后,氧消耗降至对照值的37%(对照皮层:7.0±1.3,MK-801处理皮层:2.6±3.9)。MK-801显著降低脑氧摄取,从7.1±1.3ml O2/100ml(对照皮层)降至5.3±0.6(MK-801处理皮层)。然而,谷氨酸或NMDA组处理皮层与对侧皮层之间的脑氧摄取无显著差异。谷氨酸或NMDA引起的氧消耗增加与rCBF增加相关。谷氨酸使rCBF从95±5ml/min/100g(对侧皮层)增加到165±31(处理皮层),而NMDA使rCBF从114±12(对侧皮层)增加到178±60(处理皮层)。MK-801降低氧消耗,rCBF降低幅度较小。MK-801处理皮层的rCBF为48±9,对照皮层为99±22。NMDA受体激活产生的某些物质可能与脑代谢和血流的耦合有关,因为用MK-801阻断NMDA受体后,这种关系被解除。这些发现表明谷氨酸能过程对脑氧消耗有主要影响,且这至少部分归因于NMDA受体。